Jon Kuwahara serves as Executive at Novus Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jon Kuwahara has executed 3 insider transactions totaling $10.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 21, 2019 involved selling 1,058 shares valued at $2.0K.
Jon Kuwahara currently holds 5,974 shares of Novus Therapeutics, Inc. (NVUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jon Kuwahara has been a net seller of NVUS stock. They have purchased $0 and sold $10.3K worth of shares.
Jon Kuwahara's most recent insider trade was on May 21, 2019, when they sold 1,058 shares at $1.91 per share.
Get notified when new Form 4 filings are submitted
| $1.96 |
| Discretionary |
| Mar 13, 2018 | NVUS | $0 | Award | 11,250 | $N/A | Discretionary |